Leiden University Medical Centre, Department of Surgery, Albinusdreef 2, 2333, ZA, Leiden, the Netherlands; Dutch Institute for Clinical Auditing, Rijnsburgerweg 10, 2333, AA, Leiden, the Netherlands.
Amsterdam University Medical Centres, Department of Surgery, University of Amsterdam, Cancer Centre Amsterdam, 1117 Boelelaan, 1081, HV, Amsterdam, the Netherlands.
Eur J Surg Oncol. 2022 Apr;48(4):873-882. doi: 10.1016/j.ejso.2021.10.035. Epub 2021 Nov 11.
Complications after colorectal cancer surgery can worsen long-term survival. The aim of this nationwide study was to determine the impact of different types of complications on overall survival (OS) and conditional survival if still alive one year postoperatively (CS-1) after colorectal cancer surgery.
All patients registered in the Dutch ColoRectal Audit after resection of primary colorectal cancer between 2011 and 2017 and with known survival status were included. Multivariable Cox regression models were used to assess the association of complications with OS and CS-1, thereby calculating the Hazard Ratio (HR) with 95% Confidence Interval.
43,908 colon and 16,955 rectal cancer patients were included. Median follow-up time was 66.1 and 66.5 months, respectively. Five-year OS after colon cancer resection was 73.2% without complications, and 65.4% with surgical, 52.9% with non-surgical and 51.8% with combined type of complications (p < 0.001). Corresponding 5-year OS for rectal cancer patients was 76.9%, 72.7%, 64.9%, and 63.2% (p < 0.001). In colon cancer, multivariable analyses revealed HR 1.198 (1.136-1.264) for surgical, HR 1.489 (1.423-1.558) for non-surgical and HR 1.590 (1.505-1.681) for combined type of complications. For rectal cancer, these HRs were 1.193 (1.097-1.2297), 1.456 (1.346-1.329), and 1.489 (1.357-1.633). Surgical complications were associated with worse CS-1 in rectal cancer (HR 1.140 (1.050-1.260), but not in colon cancer (HR 1.007 (0.943-1.075)).
Non-surgical complications have higher impact on survival than surgical complications. The impact of surgical complications on survival was still measurable after surviving the first year in rectal cancer but not in colon cancer patients.
结直肠癌手术后的并发症可能会恶化长期生存。本项全国性研究的目的是确定不同类型的并发症对结直肠癌手术后的总生存(OS)和如果术后仍存活一年(CS-1)的条件生存的影响。
纳入了 2011 年至 2017 年间在荷兰 ColoRectal Audit 中接受原发性结直肠癌切除术且生存状态已知的所有患者。使用多变量 Cox 回归模型评估并发症与 OS 和 CS-1 的关系,从而计算风险比(HR)及其 95%置信区间。
共纳入 43908 例结肠癌和 16955 例直肠癌患者。中位随访时间分别为 66.1 个月和 66.5 个月。无并发症的结肠癌切除术后 5 年 OS 为 73.2%,手术并发症为 65.4%,非手术并发症为 52.9%,联合并发症为 51.8%(p<0.001)。相应的直肠癌患者 5 年 OS 为 76.9%、72.7%、64.9%和 63.2%(p<0.001)。在结肠癌中,多变量分析显示手术并发症的 HR 为 1.198(1.136-1.264),非手术并发症的 HR 为 1.489(1.423-1.558),联合并发症的 HR 为 1.590(1.505-1.681)。对于直肠癌,这些 HR 分别为 1.193(1.097-1.2297)、1.456(1.346-1.329)和 1.489(1.357-1.633)。手术并发症与直肠癌 CS-1 较差相关(HR 1.140(1.050-1.260),但在结肠癌中则没有相关性(HR 1.007(0.943-1.075))。
非手术并发症对生存的影响大于手术并发症。手术并发症对生存的影响在直肠癌患者中仍然可以测量,但在结肠癌患者中则不能。